Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
-Intranasal budesonide therapy may lead to improved symptoms and sleep study findings in
children with mild obstructive sleep apnea with and without allergic rhinitis that would not
be treated with T&A. The aim of the study is to conduct a randomized double blind cross-over
trial comparing the effect of once a day intranasal budesonide therapy vs. placebo in
children with mild sleep apnea that would not be candidates for T&A.